With reference to cancer mortality and pharmaceutical regulation in India, consider the following statements: 1. India recorded 9,02,000 cancer deaths in 2025. 2. Lung cancer accounted for 98,687 of the cancer deaths in India according to WHO data. 3. The cancer fatality rate in India reached 67.8% in 2025. Which of the statements given above is/are correct?

NPPA reduces anti-cancer medicine prices as India records 9,02,000 cancer deaths in 2025

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains· 30 October 2026

Price regulation and public health accessibility: a GS2 Social Justice and healthcare policy case study.

Why in news

The National Pharmaceutical Pricing Authority (NPPA) reduced anti-cancer medicine prices effective November 9 to address the high mortality rate of 9,02,000 cancer deaths recorded in India in 2025.

Background

India recorded 1.56 million cancer cases and 9,02,000 deaths in 2025. According to WHO data, lung cancer accounted for 98,687 of these deaths, with India's cancer fatality rate at 57.8%.

Facts for Prelims

BodyNPPA: National Pharmaceutical Pricing Authority responsible for regulating medicine prices
FactIndia's cancer fatality rate: 57.8% in 2025
FactLung cancer deaths in India: 98,687 (WHO data)
FactComparative fatality rates: Bangladesh (74.3%), Nepal (70.8%), Thailand (65.5%), Pakistan (63.2%), Sri Lanka (62.8%), Indonesia (59.7%)

Prelims practice question

With reference to cancer mortality and pharmaceutical regulation in India, consider the following statements:

India recorded 9,02,000 cancer deaths in 2025.
Lung cancer accounted for 98,687 of the cancer deaths in India according to WHO data.
The cancer fatality rate in India reached 67.8% in 2025.

Which of the statements given above is/are correct?

(a)1 only
(b)1 and 2 only
(c)1 and 3 only
(d)1, 2 and 3

Show answer

Answer: (b) 1 and 2 only — Statements 1 and 2 are correct. Statement 3 is incorrect: The note states the cancer fatality rate was 57.8%.

For Mains

Q. Discuss the role of price regulation in making life-saving medicines accessible to the masses in India. How can India further reduce cancer mortality rates?

Dimensions to cover in your answer

Affordability vs Innovation: Balancing price caps under NPPA with the need for R&D incentives for domestic pharma
Infrastructure gap: Shortage of specialized oncology centers in rural areas despite lower fatality rates compared to neighbors
Public health burden: High prevalence of lung cancer necessitating targeted screening and early intervention policies

Keywords: Price Regulation · Public Health · Affordability · Pharmaceutical Policy · Cancer Mortality

Read the full news →Report a mistake in this note How notes are made Source: NDTV ↗

More Social Justice notes

Women’s Declaration International India files Supreme Court petition challenging Transgender Persons Act provisions · 30 October 2026
Union Labour Ministry constitutes boards for Unorganised, Gig and Platform Workers · 30 October 2026
Kerala High Court strikes down rule prohibiting women from working in toddy shops · 30 October 2026
Kerala High Court notes state lagging in implementing 2018 witness protection scheme · 30 October 2026
Kerala launches NoRKA Care portal offering ₹3 lakh to ₹1 crore insurance coverage · 29 October 2026
Supreme Court notes firecracker rules violated "left and right"; suggests using Virat Kohli · 29 October 2026

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.